The slip
PARKINSON RECEIPTno. 3294
19 Oct 2026, 16:46 UTCdopamine neurons, braak
predictionIRS1 in dopamine neurons tracks Braak Lewy-body stage
registeredad214490405631fd
discovery+0.37 p=0.334 n=9
replication+0.71 p=0.032 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.37, p 0.334)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT0cbee58c20af55aeb3f57f6a…
follows 6038430fa229…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 3294: IRS1 in dopamine neurons, braak
- power
- full sample +0.52 (p 0.028, n 18), 95% CI +0.07 to +0.79. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.43 (p 0.075, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.39 (p 0.109, n 18). could be the mix.
- skeptic
- leave-one-out range +0.45 to +0.61, sign flips 0; without severely affected donors +0.52 (p 0.028, n 18). robust.
- cell type
- strongest in astrocytes: -0.66 (p 0.0030, n 18) vs +0.52 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for IRS1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up IRS1 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.68 p 0.016 (needs p < 5.7e-4)